Challenges and Advances in Genome Editing Technologies in <i>Streptomyces</i>

The genome of <i>Streptomyces</i> encodes a high number of natural product (NP) biosynthetic gene clusters (BGCs). Most of these BGCs are not expressed or are poorly expressed (commonly called silent BGCs) under traditional laboratory experimental conditions. These NP BGCs represent an u...

Full description

Bibliographic Details
Main Authors: Yawei Zhao, Guoquan Li, Yunliang Chen, Yinhua Lu
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/5/734
_version_ 1797568586442604544
author Yawei Zhao
Guoquan Li
Yunliang Chen
Yinhua Lu
author_facet Yawei Zhao
Guoquan Li
Yunliang Chen
Yinhua Lu
author_sort Yawei Zhao
collection DOAJ
description The genome of <i>Streptomyces</i> encodes a high number of natural product (NP) biosynthetic gene clusters (BGCs). Most of these BGCs are not expressed or are poorly expressed (commonly called silent BGCs) under traditional laboratory experimental conditions. These NP BGCs represent an unexplored rich reservoir of natural compounds, which can be used to discover novel chemical compounds. To activate silent BGCs for NP discovery, two main strategies, including the induction of BGCs expression in native hosts and heterologous expression of BGCs in surrogate <i>Streptomyces</i> hosts, have been adopted, which normally requires genetic manipulation. So far, various genome editing technologies have been developed, which has markedly facilitated the activation of BGCs and NP overproduction in their native hosts, as well as in heterologous <i>Streptomyces</i> hosts. In this review, we summarize the challenges and recent advances in genome editing tools for <i>Streptomyces</i> genetic manipulation with a focus on editing tools based on clustered regularly interspaced short palindrome repeat (CRISPR)/CRISPR-associated protein (Cas) systems. Additionally, we discuss the future research focus, especially the development of endogenous CRISPR/Cas-based genome editing technologies in <i>Streptomyces</i>.
first_indexed 2024-03-10T19:58:06Z
format Article
id doaj.art-12602c2c648443e69dc1404e5b83246d
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T19:58:06Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-12602c2c648443e69dc1404e5b83246d2023-11-19T23:45:22ZengMDPI AGBiomolecules2218-273X2020-05-0110573410.3390/biom10050734Challenges and Advances in Genome Editing Technologies in <i>Streptomyces</i>Yawei Zhao0Guoquan Li1Yunliang Chen2Yinhua Lu3College of Life Sciences, Shanghai Normal University, Shanghai 200234, ChinaSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang 212013, ChinaSchool of Agricultural Equipment Engineering, Zhenjiang, Jiangsu University Zhenjiang 212013, ChinaCollege of Life Sciences, Shanghai Normal University, Shanghai 200234, ChinaThe genome of <i>Streptomyces</i> encodes a high number of natural product (NP) biosynthetic gene clusters (BGCs). Most of these BGCs are not expressed or are poorly expressed (commonly called silent BGCs) under traditional laboratory experimental conditions. These NP BGCs represent an unexplored rich reservoir of natural compounds, which can be used to discover novel chemical compounds. To activate silent BGCs for NP discovery, two main strategies, including the induction of BGCs expression in native hosts and heterologous expression of BGCs in surrogate <i>Streptomyces</i> hosts, have been adopted, which normally requires genetic manipulation. So far, various genome editing technologies have been developed, which has markedly facilitated the activation of BGCs and NP overproduction in their native hosts, as well as in heterologous <i>Streptomyces</i> hosts. In this review, we summarize the challenges and recent advances in genome editing tools for <i>Streptomyces</i> genetic manipulation with a focus on editing tools based on clustered regularly interspaced short palindrome repeat (CRISPR)/CRISPR-associated protein (Cas) systems. Additionally, we discuss the future research focus, especially the development of endogenous CRISPR/Cas-based genome editing technologies in <i>Streptomyces</i>.https://www.mdpi.com/2218-273X/10/5/734genome editingCRISPR/Cas<i>Streptomyces</i>microbial natural products
spellingShingle Yawei Zhao
Guoquan Li
Yunliang Chen
Yinhua Lu
Challenges and Advances in Genome Editing Technologies in <i>Streptomyces</i>
Biomolecules
genome editing
CRISPR/Cas
<i>Streptomyces</i>
microbial natural products
title Challenges and Advances in Genome Editing Technologies in <i>Streptomyces</i>
title_full Challenges and Advances in Genome Editing Technologies in <i>Streptomyces</i>
title_fullStr Challenges and Advances in Genome Editing Technologies in <i>Streptomyces</i>
title_full_unstemmed Challenges and Advances in Genome Editing Technologies in <i>Streptomyces</i>
title_short Challenges and Advances in Genome Editing Technologies in <i>Streptomyces</i>
title_sort challenges and advances in genome editing technologies in i streptomyces i
topic genome editing
CRISPR/Cas
<i>Streptomyces</i>
microbial natural products
url https://www.mdpi.com/2218-273X/10/5/734
work_keys_str_mv AT yaweizhao challengesandadvancesingenomeeditingtechnologiesinistreptomycesi
AT guoquanli challengesandadvancesingenomeeditingtechnologiesinistreptomycesi
AT yunliangchen challengesandadvancesingenomeeditingtechnologiesinistreptomycesi
AT yinhualu challengesandadvancesingenomeeditingtechnologiesinistreptomycesi